ZELSUVMI

Zelsuvmi launched into a category that had barely evolved in decades. Molluscum affects millions of children each year, yet parents were left with two frustrating choices. Painful in-office procedures or watch-and-wait care. Awareness was low and treatment felt intimidating. We built the launch around a simple human truth. Parents already have enough to worry about. That idea reframed the condition and introduced the first FDA-approved at-home prescription treatment for molluscum. The integrated campaign reached caregivers and HCPs through education, digital, social, video, and the Moms Against Molluscum community, driving 9.5K prescriptions in the first 6 months, more than 25 million impressions, 4.5 million YouTube views in two months, and hundreds of thousands of website sessions. The work also earned industry recognition, including finalist honors at the 2026 Med Ad News Manny Awards for Best Launch Campaign. 

The crazies stat about this launch: 6 weeks to create everything and get it approved. Anyone working in Pharmacutical Adversing knows how insane that is.